4D Molecular Therapeutics, Inc. announced the appointment of Uneek Mehra as Chief Business Officer of 4DMT. Mr. Mehra will lead 4DMT?s finance, business development, and precommercial functions and will be a member of 4DMT?s Executive Team, reporting to David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT. Mr. Mehra brings over 27 years of extensive leadership experience including financial, commercial, corporate strategy, and business development expertise supporting multi-billion dollar commercial-stage businesses, in addition to deep experience successfully growing and scaling emerging companies.

He previously served as a senior executive at Novartis for 13 years and as CFO & CBO of publicly traded companies, including most recently Myovant Sciences Ltd., which was recently acquired by Sumitovant Biopharma for $1.7 billion. Mr. Mehra joins 4DMT from Myovant Sciences Ltd., a public biopharma company, where, as Chief Financial and Business Officer, he successfully built partnerships, and enabled significant commercial growth for its products in Oncology and Women?s Health. Prior to joining Myovant, Mr. Mehra was Chief Financial Officer and Corporate Treasurer at PACT Pharma, a personalized cell therapy company targeting solid cancers, where he successfully built partnerships and raised capital to scale the emerging company.

Previously, Mr. Mehra was Chief Financial Officer at Proteus Digital Health, a digital medicines company, with responsibility for Finance, Tax, Treasury, IT, Facilities, and Human Resources. Mr. Mehra also spent more than 13 years at Novartis where he drove strategic investments and commercial financial performance for multi-billion-dollar businesses. He successfully led strategic portfolio prioritization and resource allocation across several business units and steered successful transactions across oncology and specialty pharma assets.

As Chief Financial Officer of the US Integrated Care and Critical Care Business Units, Mr. Mehra supported commercial excellence across multiple products; notably, driving the launch and execution of Cosentyx and Entresto. Earlier in his career, Mr. Mehra held senior finance roles with International Business Machines (IBM) Corporation and Citibank. Mr. Mehra obtained his MBA in Strategy and Leadership from the International Institute for Management Development, Lausanne, Switzerland; MS in Finance from the University of Mumbai, India; and Bachelor of Engineering in Electronics from the Birla Institute of Technology and Science, Pilani, India.